Screening compound: C15H17N3O2S (S069-3992)

Screening compound: C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>S (S069-3992)
Screening compound: C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>S (S069-3992) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C15H17N3O2S (S069-3992)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S069-3992

Molecular Formula

C15H17N3O2S (C15 H17 N3 O2 S)

Compound Name

1-[3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)pyrrolidin-1-yl]-2-(thiophen-3-yl)ethan-1-one

IUPAC name

1-[3-(5-cyclopropyl-124-oxadiazol-3-yl)pyrrolidin-1-yl]-2-(thiophen-3-yl)ethan-1-one

SMILES

O=C(Cc1cscc1)N(CC1)CC1c1noc(C2CC2)n1

InChI

InChI=1S/C15H17N3O2S/c19-13(7-10-4-6-21-9-10)18-5-3-12(8-18)14-16-15(20-17-14)11-1-2-11/h4,6,9,11-12H,1-3,5,7-8H2/t12-/m1/s1

InChI Key

HXKYQLRAEMQREG-GFCCVEGCSA-N

MDL Number (MFCD)

MFCD29007430

C15H17N3O2S (S069-3992) in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C15H17N3O2S (S069-3992) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C15H17N3O2S (S069-3992)?
Check Price and Availability of C15H17N3O2S (S069-3992), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C15H17N3O2S (S069-3992) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C15H17N3O2S (S069-3992)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C15H17N3O2S (S069-3992)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C15H17N3O2S (S069-3992) available by request